21 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
19 Feb 19
Asset Purchase Agreement
4:57pm
for rejection, defect, damaged goods, recall or return of any Product or for retroactive price reductions and billing errors;
(iv) administrative fees paid
6-K
EX-1.1
ENLV
Enlivex Therapeutics Ltd
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional materials
6-K
EX-1.1
ENLV
Enlivex Therapeutics Ltd
5 Mar 20
Report of Foreign Private Issuer
8:16am
of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws
6-K
EX-10.1
ENLV
Enlivex Therapeutics Ltd
22 Oct 20
Report of Foreign Private Issuer
8:47am
or packaging of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall
6-K
EX-10.1
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Report of Foreign Private Issuer
4:02pm
Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal
6-K
EX-1.1
otssz
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
20-F
lt6xyp6
31 Mar 15
Annual report (foreign)
12:00am
F-1/A
to2 t1i98vnaci
8 Jul 14
Registration statement (foreign) (amended)
12:00am
424B4
x6m2xfbft4e95
31 Jul 14
Prospectus supplement with pricing info
12:00am
6-K
EX-99.1
m7yt6qfw9 mndgk
19 Nov 18
Agreement and Plan of Merger
4:34pm
20-F/A
jgfs2v
23 Jan 20
Annual report (foreign) (amended)
4:31pm